Search

Displaying results 4881 - 4890 of 10000 in total
  1. Pathway

    Vitamin A Deficiency

    smpdb.ca/view/SMP0125788
    Disease

    Vitamin A deficiency can be caused by many causes. A defect in the BCMO1 gene which codes for beta,beta-carotene 15,15’-monooxygenase is one of them. … A defect in this enzyme results in decrease of levels of retinal and vitamin A in serum; Signs and symptoms include night blindness, poor adaptation to darkness, dry skin and hair.

    Drugs: NADH · Vitamin A · Alitretinoin · Tretinoin · Iron · Zinc +2 more
  2. Pathway

    Vitamin A Deficiency

    smpdb.ca/view/SMP0000336
    Disease

    Vitamin A deficiency can be caused by many causes. A defect in the BCMO1 gene which codes for beta,beta-carotene 15,15’-monooxygenase is one of them. … A defect in this enzyme results in decrease of levels of retinal and vitamin A in serum; Signs and symptoms include night blindness, poor adaptation to darkness, dry skin and hair.

    Drugs: NADH · Vitamin A · Alitretinoin · Tretinoin · Iron · Zinc +2 more
  3. Drug

    Famprofazone

    go.drugbank.com/drugs/DB16702
    Experimental

    [L34724] It is important to note that the drug is metabolized to [methamphetamine] and [amphetamine] in the body and can lead to positive tests results for illicit drug use. … Famprofazone is a nonsteroidal anti-inflammatory agent found in combination products such as ‘Gewodin’ which is marketed in Taiwan.

    Categories: Amphetamines, Heterocyclic Compounds, 1-Ring
  4. Target

    ATP-dependent 6-phosphofructokinase, muscle type

    go.drugbank.com/bio_entities/BE0012586
    TargetHumans

    Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis

    Synonyms: PFK-A, 6-phosphofructokinase type A
  5. Drug

    Exemestane

    go.drugbank.com/drugs/DB00990
    ApprovedInvestigational

    Exemestane is an oral steroidal aromatase inhibitor used in the adjuvant treatment of hormonally-responsive (also called hormone-receptor-positive, estrogen-responsive) breast cancer in postmenopausal

    Synonyms: 6-methyleneandrosta-1,4-diene-3,17-dioneCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
  6. Target

    Fe(3+) ABC transporter substrate-binding protein

    go.drugbank.com/bio_entities/BE0002664
    TargetPasteurella haemolytica

    Polypeptides: Fe(3+) ABC transporter substrate-binding proteinSynonyms: Periplasmic iron binding protein A FbpA
  7. Target

    Phospholipase A1

    go.drugbank.com/bio_entities/BE0002041
    TargetEscherichia coli (strain K12)

    Has broad substrate specificity including hydrolysis of phosphatidylcholine with phospholipase A2 (EC 3.1.1.4) and phospholipase A1 (EC 3.1.1.32) activities. Strong expression leads to outer membrane breakdown and cell death; is dormant ...

    Synonyms: DR-phospholipase A, Outer membrane phospholipase A
  8. Drug

    Acorus calamus root

    go.drugbank.com/drugs/DB14292
    Investigational

    Acorus calamus root is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

    Products: derma MOBALNA EP 90 Hair Again Toner
  9. Drug

    Etilamfetamine

    go.drugbank.com/drugs/DB13285
    Experimental

    Like other amphetamines, this amphetamine analog was used as an appetite suppressant in the 1950s. … Etilamfetamine is also known as N-ethylamphetamine and is in the Canadian Legislation - The Controlled Drugs and Substances Act, and is a Schedule 1 controlled drug.

  10. Target

    Interferon alpha-2

    go.drugbank.com/bio_entities/BE0003450
    TargetHumans

    Produced by macrophages, IFN-alpha have antiviral activities

    Synonyms: LeIF A, Interferon alpha-A